|
Virus Information Hepatitis C is a disease characterized by inflammation
of the liver. Inflammation of the liver may be caused by a number
of viruses, including the hepatitis C virus, as well as by alcohol,
drugs, and certain chemical compounds.
It has long been known that a form of viral hepatitis distinct from
both hepatitis A and B existed, but it was only in 1989 that the
hepatitis C virus was first identified.
Hepatitis C is transmitted mainly by direct contact with infected
blood or blood products. Although there have been many reported
cases of hepatitis C being transmitted through blood products before
these were screened for the virus, modern screening techniques have
virtually eliminated the risk of hepatitis C transmission to users
of Canada's blood system.
Currently, the major mode of contracting hepatitis C is through
the sharing of contaminated needles and other instruments among
injection drug users. Other risk behaviours include using contaminated
equipment for tattooing, body piercing, acupuncture, and intra nasal
(snorting) cocaine use. Current research tells us that the risks
of transmitting hepatitis C through sexual intercourse or childbearing
are low.
![Top of Page](/web/20061211035640im_/http://www.phac-aspc.gc.ca/hepc/hepatitis_c/gfx/pi_top_of_page.gif)
Although some people may experience symptoms such as fatigue and
jaundice following initial infection (acute stage) with the hepatitis
C virus (HCV), many others have no symptoms. Because the disease
progresses slowly in the body, symptoms can appear many years after
initial infection (chronic stage). In Canada, it is estimated that
250,000 persons are currently infected with hepatitis, and approximately
one-third of those living with HCV are unaware of their infection.
It is estimated that 5,000 newly diagnosed infections occur each
year; and approximately 1,000 persons in Canada die annually from
this disease. In Canada, the majority of new infections result
from the use of contaminated drug injection equipment.
Approximately 10-20% of persons infected with hepatitis C develop
cirrhosis of the liver. Cirrhosis is a severe degenerative disease
that causes liver cells to be damaged and replaced by scar tissue.
It can lead to liver failure resulting in the need for a liver
transplant; liver cancer (hepatocellular carcinoma); death. As
the liver ceases to function properly, it loses its ability to
perform the important functions such as breaking down foods in
the digestive process, storing vitamins and minerals, producing
proteins required for blood clotting, and cleansing the blood
of toxic substances.
In Canada, there are a few approved drug therapies
to treat chronic hepatitis C infection in adult patients.
Currently, there exists no vaccine to protect people from contracting
the hepatitis C virus.
![Top of Page](/web/20061211035640im_/http://www.phac-aspc.gc.ca/hepc/hepatitis_c/gfx/pi_top_of_page.gif)
|